CPT code 33897 denotes a transcatheter, minimally invasive angioplasty to widen coarctation of the aorta, a congenital narrowing that can impair systemic blood flow. This procedure is a key endovascular alternative to open surgical repair and is used to reduce pressure gradients and improve hemodynamics in affected patients. Nationally, the code is relevant to hospitals, cardiac catheterization laboratories, and specialists managing congenital and structural heart disease.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and payer relevance, along with what to expect in billing and reimbursement benchmarking. The publication also outlines common modifiers and related administrative considerations where available.

The report provides: clinical context for when transcatheter angioplasty for coarctation is applied; a summary of payer coverage considerations and common modifiers used in practice; and guidance on interpreting related service lines and coding relationships. Data not available in the input will be noted as such in relevant sections. The content is intended for a national audience of hospital administrators, cardiology program directors, and revenue cycle professionals.